Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This intensive medical management (IMT) protocol is a multi-modal therapeutic strategy developed by the Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, specifically for the management of obese patients with type 2 diabetes mellitus. It was utilized as the medical comparator arm in clinical trials evaluating the efficacy of laparoscopic sleeve gastrectomy. The protocol consists of a combination of pharmacological agents—including the GLP-1 receptor agonist exenatide, the biguanide metformin, and the long-acting basal insulin analog insulin detemir—integrated with a very low-calorie diet (VLCD) providing approximately 800 kcal/day. The intervention aims to achieve aggressive glycemic targets (HbA1c < 7%) and significant weight loss by simultaneously targeting insulin secretion, hepatic glucose production, and caloric intake.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on intensive medical management-Post Graduate Institute of Medical Education and Research, Chandigarh-type 2 diabetes mellitus-obesity.